Botulinum toxin
Isolated treatment with intradermal injection of botulinum toxin type A into circumscribed areas of LSC resulted in resolution of pruritus within 3 to 7 days and clearing of these LSC lesions within 2 to 4 weeks in one small study (5 lesions in 3 patients).[52]Heckmann M, Heyer G, Brunner B, et al. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol. 2002;46:617-619.
http://www.ncbi.nlm.nih.gov/pubmed/11907521?tool=bestpractice.com
The mechanism behind this effect is hypothesised to be secondary to the blockade of acetylcholine, a mediator of pruritus in atopic dermatitis. Another study found that botulinum toxin injection significantly reduced the Eczema Area and Severity Index (EASI) score in patients with LSC, but 4/12 patients experienced recurrence after 3 months.[53]Gharib K, Mostafa A, Elsayed A. Evaluation of botulinum toxin type A injection in the treatment of localized chronic pruritus. J Clin Aesthet Dermatol. 2020 Dec;13(12):12-17.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819596
http://www.ncbi.nlm.nih.gov/pubmed/33488912?tool=bestpractice.com
Acupuncture and electroacupuncture
Acupuncture and electroacupuncture (low-voltage, high-frequency electrical stimulation applied to acupuncture needles) have been used to treat LSC and may act by reducing proinflammatory neuropeptides in inflamed skin. One meta-analysis reported that acupuncture resulted in improved effectiveness and reduced recurrence compared with a control of conventional drug treatment; however, the level of evidence was limited by the small number of studies, small sample sizes, and uncertain risk of bias.[54]Yang L, Li X, Huang W, et al. The Efficacy and safety of acupuncture in the treatment of neurodermatitis: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022;2022:8182958.
https://www.hindawi.com/journals/ecam/2022/8182958
http://www.ncbi.nlm.nih.gov/pubmed/36091587?tool=bestpractice.com
Gabapentin
Treatment with gabapentin for 4 to 10 months led to total or partial remission of LSC in one case report.[55]Gencoglan G, Inanir I, Gunduz K. Therapeutic hotline: treatment of prurigo
nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther. 2010;23:194-198.
http://www.ncbi.nlm.nih.gov/pubmed/20415827?tool=bestpractice.com
Topical aspirin or salicylic acid
One randomised trial of 29 patients with LSC found a significant therapeutic response in 46% of patients treated with topical aspirin versus 12% who received placebo.[56]Yosipovitch G, Sugeng MW, Chan YH, et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 2001 Dec;45(6):910-3.
http://www.ncbi.nlm.nih.gov/pubmed/11712038?tool=bestpractice.com
Topical corticosteroids combined with keratolytics like salicylic acid may also be effective for LSC.[6]Ju T, Vander Does A, Mohsin N, et al. Lichen simplex chronicus itch: an update. Acta Derm Venereol. 2022 Oct 19;102:adv00796.
https://medicaljournalssweden.se/actadv/article/view/4367/7436
http://www.ncbi.nlm.nih.gov/pubmed/36250769?tool=bestpractice.com
Topical ketamine plus lidocaine plus amitriptyline
An analgesic mixture thought to relieve pruritus by reducing hypersensitivity of peripheral nerve fibers.[6]Ju T, Vander Does A, Mohsin N, et al. Lichen simplex chronicus itch: an update. Acta Derm Venereol. 2022 Oct 19;102:adv00796.
https://medicaljournalssweden.se/actadv/article/view/4367/7436
http://www.ncbi.nlm.nih.gov/pubmed/36250769?tool=bestpractice.com
[57]Lee HG, Grossman SK, Valdes-Rodriguez R, et al. Topical ketamine-amitriptyline-lidocaine for chronic pruritus: a retrospective study assessing efficacy and tolerability. J Am Acad Dermatol. 2017 Apr;76(4):760-1.
https://www.jaad.org/article/S0190-9622(16)31005-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/28325395?tool=bestpractice.com
One retrospective study reported it was effective for patients with chronic pruritus, including some patients with LSC.[57]Lee HG, Grossman SK, Valdes-Rodriguez R, et al. Topical ketamine-amitriptyline-lidocaine for chronic pruritus: a retrospective study assessing efficacy and tolerability. J Am Acad Dermatol. 2017 Apr;76(4):760-1.
https://www.jaad.org/article/S0190-9622(16)31005-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/28325395?tool=bestpractice.com